Cargando…

Identification of endothelial-related molecular subtypes for bladder cancer patients

BACKGROUND: Bladder cancer (BC) is a disease with significant heterogeneity and poor prognosis. The prognosis and therapeutic response of BC patients are significantly influenced by endothelial cells in the tumor microenvironment. In order to understand BC from the perspective of endothelial cells,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Deng-xiong, Feng, De-chao, Shi, Xu, Wu, Rui-cheng, Chen, Kai, Han, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070733/ https://www.ncbi.nlm.nih.gov/pubmed/37025597 http://dx.doi.org/10.3389/fonc.2023.1101055

Ejemplares similares

M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
por: Li, Deng-xiong, et al.
Publicado: (2023)

Lymphocyte-to-Monocyte Ratio (LMR) During Induction Is a Better Predictor Than Preoperative LMR in Patients Receiving Intravesical Bacillus Calmette -Guerin for Non-Muscle-Invasive Bladder Cancer
por: Li, Deng-xiong, et al.
Publicado: (2022)

Traditional Classification and Novel Subtyping Systems for Bladder Cancer
por: Zhu, Shaoming, et al.
Publicado: (2020)

CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes
por: Liu, Yi, et al.
Publicado: (2021)

Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets
por: Tang, Chaozhi, et al.
Publicado: (2020)

Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients
por: Cai, Hai, et al.
Publicado: (2021)

Identification of cuproptosis-based molecular subtypes, construction of prognostic signature and characterization of immune landscape in colon cancer
por: Wang, Xu, et al.
Publicado: (2023)

Identification of senescence-related molecular subtypes and key genes for prostate cancer
por: Feng, De-Chao, et al.
Publicado: (2022)

Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer
por: Zhu, Jiaqi, et al.
Publicado: (2022)

Identification of Distinct Immune Subtypes in Colorectal Cancer Based on the Stromal Compartment
por: Shen, Rongfang, et al.
Publicado: (2020)

Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment
por: Yang, Jianfeng, et al.
Publicado: (2022)

Identification of Subtype-Specific Metastasis-Related Genetic Signatures in Sarcoma
por: Li, Ya-Ling, et al.
Publicado: (2020)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy
por: Feng, Dechao, et al.
Publicado: (2022)

Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer
por: Wu, Zixuan, et al.
Publicado: (2023)

Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer
por: Zhang, Jili, et al.
Publicado: (2023)

Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy
por: Chen, Can, et al.
Publicado: (2023)

Inflammation-related research within the field of bladder cancer: a bibliometric analysis
por: Deng, Zhixuan, et al.
Publicado: (2023)

Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer
por: Zhong, Xiaoxiao, et al.
Publicado: (2021)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity
por: Yang, Xiao, et al.
Publicado: (2022)

Identification of Epithelial–Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma
por: Zhong, Weimin, et al.
Publicado: (2020)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

Molecular subtypes and tumor microenvironment infiltration signatures based on cuproptosis-related genes in colon cancer
por: Luo, Hongwei, et al.
Publicado: (2023)

Unraveling Immune-Related lncRNAs in Breast Cancer Molecular Subtypes
por: Mathias, Carolina, et al.
Publicado: (2021)

Identification of an immunotherapy-responsive molecular subtype of bladder cancer
por: Song, Bic-Na, et al.
Publicado: (2019)

Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer
por: Feng, Lixiang, et al.
Publicado: (2022)

Molecular subtypes, clinical significance, and tumor immune landscape of angiogenesis-related genes in ovarian cancer
por: Tang, Haixia, et al.
Publicado: (2022)

Identification of N6-Methylandenosine-Related lncRNAs for Subtype Identification and Risk Stratification in Gastric Adenocarcinoma
por: Huang, Yuancheng, et al.
Publicado: (2021)

The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas
por: Ba, Yueyang, et al.
Publicado: (2022)

Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer
por: Jiang, Xuewen, et al.
Publicado: (2021)

Molecular Subtypes and Prognostic Signature of Pyroptosis-Related lncRNAs in Glioma Patients
por: Tanzhu, Guilong, et al.
Publicado: (2022)

PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer
por: Zhang, Biao, et al.
Publicado: (2023)

Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis
por: Na, Lei, et al.
Publicado: (2020)

Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer
por: Sun, Jiale, et al.
Publicado: (2021)

Necroptosis-Related Genes Signatures Identified Molecular Subtypes and Underlying Mechanisms in Hepatocellular Carcinoma
por: Wei, Jianguo, et al.
Publicado: (2022)

Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics
por: Shu, Yuan, et al.
Publicado: (2022)

Update on bladder cancer molecular subtypes
por: Fong, Megan Hoi Yan, et al.
Publicado: (2020)

Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma
por: Wang, Zhifeng, et al.
Publicado: (2022)

Molecular Subtypes and CD4(+) Memory T Cell-Based Signature Associated With Clinical Outcomes in Gastric Cancer
por: Ning, Zhi-Kun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dikl5v0u0mbogjl9v6tih5irlo